Photobiomodulation therapy (PBMT) is a non-thermal therapeutic procedure widely used in clinical practice. It is considered an effective modality of treatment for the control of various inflammatory conditions with fewer adverse effects as compared to conventional therapy. However, despite the clinical effects, the mechanisms of action and dosimetric parameters of PBMT are not fully understood. This study was performed to describe the effects of two different doses of PBMT on experimental models of inflammation. Male Swiss mice were administered with 0.9% of saline or phlogistic agents (carrageenan, dextran, serotonin, histamine, or bradykinin) by intra-plantar injection and were treated with PBMT at a dose of 1 or 5 J/cm; right after, the variation of the paw volume was made, and histopathological analysis and myeloperoxidase assay of the carrageenan-induced edematous paw tissues were performed. The action of PBMT on carrageenan-induced vascular permeability was further evaluated. Our results showed that PBMT (1 J/cm) led to an improvement in paw edema induced by the phlogistic agents and further reduced the histological scores. Inhibition of neutrophil migration was observed following the administration of 1 and 5 J/cm of PBMT. However, only 1 J/cm of PBMT showed beneficial effects on carrageenan-induced edema. Laser at a dose of 1 J/cm showed cellular and vascular effects since it was able to reverse all the inflammatory parameters, and laser at a dose of 5 J/cm probably has only cellular effects in the presence of acute inflammation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10103-021-03298-x | DOI Listing |
Clin Positron Imaging
October 1999
Departments of Nuclear Medicine, Technische Universität München, Munich, Germany
Breast cancer represents the most frequent malignant disease in women and the second leading cause of cancer death in western countries. Current available treatment includes surgery, radiation therapy, chemotherapy, and hormonal therapy. The disease is often curable when detected in early stages.
View Article and Find Full Text PDFJ Nucl Med
December 1999
Department of Nuclear Medicine, University Hospital Eppendorf, Hamburg, Germany.
Unlabelled: The aim of this study was to compare the visual analysis of attenuation-corrected and noncorrected 18F-fluoro-2-deoxy-D-glucose (FDG) PET images in patients with primary or metastatic breast cancer using standardized film documentation and to evaluate the influence of attenuation correction on lesion detectability.
Methods: Standard FDG PET of the breasts and of the axillary regions was performed on 28 women with breast cancer. Transmission scans were acquired for attenuation correction after administration of FDG.
Radiologe
September 1997
Nuklearmedizinische Klinik, Technische Universität, München.
Based on the increased glucose metabolism of malignant tissue, positron emission tomography (PET), using the radiolabeled glucose analog 18F-fluorodeoxyglucose (FDG), allows identification of breast cancer. Based on the criteria implemented in image interpretation, sensitivity of PET imaging ranged from 68% to 94% with a specificity between 84% and 97%. However, sensitivity for small tumors (< 1 cm) was found to be low.
View Article and Find Full Text PDFJ Natl Cancer Inst
September 1996
Department of Nuclear Medicine, Technische Universität München, Federal Republic of Germany.
Background: The presence of metastatic tumor cells in the axillary lymph nodes is an important factor when deciding whether or not to treat breast cancer patients with adjuvant therapy. Positron emission tomography (PET) imaging with the radiolabeled glucose analogue 2-(fluorine-18)-fluoro-2-deoxy-D-glucose (F-18 FDG) has been used to visualize primary breast tumors as well as bone and soft-tissue metastases.
Purpose: This study was undertaken to evaluate before surgery the diagnostic accuracy of PET for detection of axillary lymph node metastases in patients suspected of having breast cancer.
J Clin Oncol
June 1996
Department of Nuclear Medicine, Technische Universität München, Germany.
Purpose: To evaluate the diagnostic value of position emission tomographic (PET) imaging with F-18 fluorodeoxyglucose (FDG) in differentiating between benign and malignant breast tumors.
Patients And Methods: Fifty-one patients, with suspicious breast lesions newly discovered either by physical examination or by mammography, underwent PET imaging before exploratory surgery. FDG-PET images of the breast were analyzed visually and quantitatively for objective assessment of regional tracer uptake.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!